GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (OTCPK:KKPCF) » Definitions » Cyclically Adjusted PB Ratio

Kaken Pharmaceutical Co (Kaken Pharmaceutical Co) Cyclically Adjusted PB Ratio : 0.84 (As of Jun. 18, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-06-18), Kaken Pharmaceutical Co's current share price is $22.63. Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $26.87. Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 0.84.

The historical rank and industry rank for Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

KKPCF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 2.02   Max: 3.7
Current: 1.22

During the past years, Kaken Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 3.70. The lowest was 1.06. And the median was 2.02.

KKPCF's Cyclically Adjusted PB Ratio is ranked better than
66.18% of 751 companies
in the Drug Manufacturers industry
Industry Median: 1.85 vs KKPCF: 1.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kaken Pharmaceutical Co's adjusted book value per share data for the three months ended in Dec. 2023 was $25.701. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $26.87 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.38 1.87 1.51 1.29 -

Kaken Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.29 1.23 1.16 1.09 -

Competitive Comparison of Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=22.63/26.87
=0.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Kaken Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=25.701/106.8000*106.8000
=25.701

Current CPI (Dec. 2023) = 106.8000.

Kaken Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 15.749 95.700 17.576
201406 15.571 98.000 16.969
201409 15.293 98.500 16.582
201412 14.318 97.900 15.620
201503 15.458 97.900 16.863
201506 15.778 98.400 17.125
201509 17.195 98.500 18.644
201512 18.286 98.100 19.908
201603 19.220 97.900 20.967
201606 20.644 98.100 22.475
201609 22.479 98.000 24.498
201612 20.581 98.400 22.338
201703 22.243 98.100 24.216
201706 23.119 98.500 25.067
201709 24.270 98.800 26.235
201712 24.508 99.400 26.333
201803 26.632 99.200 28.672
201806 25.630 99.200 27.594
201809 26.318 99.900 28.136
201812 26.535 99.700 28.425
201903 27.440 99.700 29.394
201906 28.384 99.800 30.375
201909 29.432 100.100 31.402
201912 29.805 100.500 31.673
202003 30.660 100.300 32.647
202006 31.050 99.900 33.195
202009 32.362 99.900 34.597
202012 33.184 99.300 35.690
202103 32.713 99.900 34.972
202106 32.348 99.500 34.721
202109 33.203 100.100 35.425
202112 32.314 100.100 34.477
202203 30.716 101.100 32.448
202206 27.194 101.800 28.530
202209 26.038 103.100 26.972
202212 27.716 104.100 28.435
202303 27.204 104.400 27.829
202306 25.911 105.200 26.305
202309 25.401 106.200 25.545
202312 25.701 106.800 25.701

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kaken Pharmaceutical Co  (OTCPK:KKPCF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaken Pharmaceutical Co (Kaken Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (Kaken Pharmaceutical Co) Headlines

No Headlines